Skip to content

Clinical trials

Phase 2 Substance-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 2 Country / region: United States Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20033
20044
200510
200610
200715
20086
200915
201010
20114
20126
20134
20147
20151
20163
20174
20182
20193
20202
20214
20222
20234
20243
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed133
Unknown status15
Withdrawn8
Recruiting7
Terminated6
Not yet recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)23
Medical University of South Carolina13
Yale University10
University of Chicago7
Johns Hopkins University6
New York State Psychiatric Institute6
VA Office of Research and Development5
The University of Tennessee, Knoxville4
Boston Medical Center3
San Francisco Department of Public Health3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders174
Opioid-Related Disorders34
Cocaine-Related Disorders28
Alcoholism26
Stress Disorders, Post-Traumatic9
HIV Infections7
Heroin Dependence7
Alcohol-Related Disorders6
Mental Disorders6
Anxiety Disorders4

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.